{"config":{"lang":["en"],"min_search_length":3,"prebuild_index":false,"separator":"[\\s\\-]+"},"docs":[{"location":"","text":"Welcome to MkDocs For full documentation visit mkdocs.org . Commands mkdocs new [dir-name] - Create a new project. mkdocs serve - Start the live-reloading docs server. mkdocs build - Build the documentation site. mkdocs -h - Print help message and exit. Project layout mkdocs.yml # The configuration file. docs/ index.md # The documentation homepage. ... # Other markdown pages, images and other files.","title":"Welcome to MkDocs"},{"location":"#welcome-to-mkdocs","text":"For full documentation visit mkdocs.org .","title":"Welcome to MkDocs"},{"location":"#commands","text":"mkdocs new [dir-name] - Create a new project. mkdocs serve - Start the live-reloading docs server. mkdocs build - Build the documentation site. mkdocs -h - Print help message and exit.","title":"Commands"},{"location":"#project-layout","text":"mkdocs.yml # The configuration file. docs/ index.md # The documentation homepage. ... # Other markdown pages, images and other files.","title":"Project layout"},{"location":"01-%E5%BF%83/01-01-Electrocardiography/","text":"1. Electrocardiography Approach (*a systematic approach is vital*)** \u2022 Rate (? tachy, brady) and rhythm (? relationship between P and QRS) \u2022 Intervals (PR, QRS, QT) and axis (? LAD or RAD) \u2022 Chamber abnormality (? LAA and/or RAA, ? LVH and/or RVH) \u2022 QRST changes (? Q waves, poor R-wave progression V1\u2013V6, ST \u2191/\u2193 or T-wave \u0394s) Figure 1-1\u2002QRS axis Left axis deviation (LAD) \u2022 Definition : axis beyond \u201330\u00b0 (S > R in lead II) \u2022 Etiologies : LVH, LBBB, inferior MI, WPW \u2022 Left anterior fascicular block : LAD (\u201345 to \u201390\u00b0) and qR in aVL and QRS <120 msec and no other cause of LAD (eg, IMI) Right axis deviation (RAD) \u2022 Definition : axis beyond +90\u00b0 (S > R in lead I) \u2022 Etiologies : RVH, PE, COPD (usually not > +110\u00b0), septal defects, lateral MI, WPW \u2022 Left posterior fascicular block : RAD (90\u2013180\u00b0) and rS in I & aVL and qR in III & aVF and QRS <120 msec and no other cause of RAD Prolonged QT interval (*NEJM* 2008;358:169; www.torsades.org ) \u2022 QT measured from beginning of QRS complex to end of T wave (measure longest QT) \u2022 QT varies w/ HR \u2192 correct w/ Bazett formula: QTc = QT/\u221aRR (in sec), formula inaccurate at very high and low HR (nl QTc <440 msec \u7537 and <460 msec \u5973) \u2022 QT prolongation a/w \u2191 risk TdP (esp. >500 msec); perform baseline/serial ECGs if using QT prolonging meds, no estab guidelines for stopping Rx if QT prolongs \u2022 Etiologies: Antiarrhythmics : class Ia (procainamide, disopyramide), class III (amiodarone, sotalol) Psych drugs : antipsychotics (phenothiazines, haloperidol, atypicals), Li, ? SSRI, TCA Antimicrobials : macrolides, quinolones, azoles, pentamidine, atovaquone, atazanavir Other : antiemetics (droperidol, 5-HT3 antagonists), alfuzosin, methadone, ranolazine Electrolyte disturbances : hypoCa (nb, hyperCa a/w \u2193 QT), ? hypoK, ? hypoMg Autonomic dysfxn : ICH (deep TWI), stroke, carotid endarterectomy, neck dissection Congenital (long QT syndrome): K, Na, Ca channelopathies ( Circ 2013;127:126) Misc : CAD, CMP, bradycardia, high-grade AVB, hypothyroidism, hypothermia, BBB","title":"1. Electrocardiography"},{"location":"01-%E5%BF%83/01-01-Electrocardiography/#1-electrocardiography","text":"","title":"1. Electrocardiography"},{"location":"01-%E5%BF%83/01-01-Electrocardiography/#approach-a-systematic-approach-is-vital","text":"\u2022 Rate (? tachy, brady) and rhythm (? relationship between P and QRS) \u2022 Intervals (PR, QRS, QT) and axis (? LAD or RAD) \u2022 Chamber abnormality (? LAA and/or RAA, ? LVH and/or RVH) \u2022 QRST changes (? Q waves, poor R-wave progression V1\u2013V6, ST \u2191/\u2193 or T-wave \u0394s) Figure 1-1\u2002QRS axis Left axis deviation (LAD) \u2022 Definition : axis beyond \u201330\u00b0 (S > R in lead II) \u2022 Etiologies : LVH, LBBB, inferior MI, WPW \u2022 Left anterior fascicular block : LAD (\u201345 to \u201390\u00b0) and qR in aVL and QRS <120 msec and no other cause of LAD (eg, IMI) Right axis deviation (RAD) \u2022 Definition : axis beyond +90\u00b0 (S > R in lead I) \u2022 Etiologies : RVH, PE, COPD (usually not > +110\u00b0), septal defects, lateral MI, WPW \u2022 Left posterior fascicular block : RAD (90\u2013180\u00b0) and rS in I & aVL and qR in III & aVF and QRS <120 msec and no other cause of RAD Prolonged QT interval (*NEJM* 2008;358:169; www.torsades.org ) \u2022 QT measured from beginning of QRS complex to end of T wave (measure longest QT) \u2022 QT varies w/ HR \u2192 correct w/ Bazett formula: QTc = QT/\u221aRR (in sec), formula inaccurate at very high and low HR (nl QTc <440 msec \u7537 and <460 msec \u5973) \u2022 QT prolongation a/w \u2191 risk TdP (esp. >500 msec); perform baseline/serial ECGs if using QT prolonging meds, no estab guidelines for stopping Rx if QT prolongs \u2022 Etiologies: Antiarrhythmics : class Ia (procainamide, disopyramide), class III (amiodarone, sotalol) Psych drugs : antipsychotics (phenothiazines, haloperidol, atypicals), Li, ? SSRI, TCA Antimicrobials : macrolides, quinolones, azoles, pentamidine, atovaquone, atazanavir Other : antiemetics (droperidol, 5-HT3 antagonists), alfuzosin, methadone, ranolazine Electrolyte disturbances : hypoCa (nb, hyperCa a/w \u2193 QT), ? hypoK, ? hypoMg Autonomic dysfxn : ICH (deep TWI), stroke, carotid endarterectomy, neck dissection Congenital (long QT syndrome): K, Na, Ca channelopathies ( Circ 2013;127:126) Misc : CAD, CMP, bradycardia, high-grade AVB, hypothyroidism, hypothermia, BBB","title":"Approach (*a systematic approach is vital*)**"},{"location":"01-%E5%BF%83/01-02-Chest-Pain/","text":"","title":"01 02 Chest Pain"},{"location":"01-%E5%BF%83/01-03-Noninvasive-Evaluation-of-CAD/","text":"","title":"01 03 Noninvasive Evaluation of CAD"},{"location":"01-%E5%BF%83/01-04-Coronary-Angiography-and-Revascularization/","text":"","title":"01 04 Coronary Angiography and Revascularization"},{"location":"01-%E5%BF%83/01-05-Acute-Coronary-Syndromes/","text":"","title":"01 05 Acute Coronary Syndromes"},{"location":"01-%E5%BF%83/01-06-PA-Catheter-and-Tailored-Therapy/","text":"","title":"01 06 PA Catheter and Tailored Therapy"},{"location":"01-%E5%BF%83/01-07-Heart-Failure/","text":"","title":"01 07 Heart Failure"},{"location":"01-%E5%BF%83/01-08-Cardiomyopathies/","text":"","title":"01 08 Cardiomyopathies"},{"location":"01-%E5%BF%83/01-09-Valvular-Heart-Disease/","text":"","title":"01 09 Valvular Heart Disease"},{"location":"01-%E5%BF%83/01-10.Pericardial-Disease/","text":"","title":"01 10.Pericardial Disease"},{"location":"01-%E5%BF%83/01-11.Hypertension/","text":"","title":"01 11.Hypertension"},{"location":"01-%E5%BF%83/01-12.Aortic-Aneurysms/","text":"","title":"01 12.Aortic Aneurysms"},{"location":"01-%E5%BF%83/01-13.Acute-Aortic-Syndromes/","text":"","title":"01 13.Acute Aortic Syndromes"},{"location":"01-%E5%BF%83/01-14.Arrhythmias/","text":"","title":"01 14.Arrhythmias"},{"location":"01-%E5%BF%83/01-15.Atrial-Fibrillation/","text":"","title":"01 15.Atrial Fibrillation"},{"location":"01-%E5%BF%83/01-16.Syncope/","text":"","title":"01 16.Syncope"},{"location":"01-%E5%BF%83/01-17.Cardiac-Rhythm-Management-Devices/","text":"","title":"01 17.Cardiac Rhythm Management Devices"},{"location":"01-%E5%BF%83/01-18.Cardiac-Risk-Assessment-for-Noncardiac-Surgery/","text":"","title":"01 18.Cardiac Risk Assessment for Noncardiac Surgery"},{"location":"01-%E5%BF%83/01-19.Peripheral-Artery-Disease/","text":"","title":"01 19.Peripheral Artery Disease"},{"location":"02-%E8%82%BA/02-01-Dyspnea-Pulmonary/","text":"","title":"02 01 Dyspnea Pulmonary"},{"location":"02-%E8%82%BA/02-02-Function-Tests/","text":"","title":"02 02 Function Tests"},{"location":"02-%E8%82%BA/02-03-Asthma/","text":"","title":"02 03 Asthma"},{"location":"02-%E8%82%BA/02-04-Anaphylaxis/","text":"","title":"02 04 Anaphylaxis"},{"location":"02-%E8%82%BA/02-05-Chronic-Obstructive/","text":"","title":"02 05 Chronic Obstructive"},{"location":"02-%E8%82%BA/02-06-Pulmonary-Disease/","text":"","title":"02 06 Pulmonary Disease"},{"location":"02-%E8%82%BA/02-07-Solitary-Pulmonary-Nodule/","text":"","title":"02 07 Solitary Pulmonary Nodule"},{"location":"02-%E8%82%BA/02-08.Hemoptysis/","text":"","title":"02 08.Hemoptysis"},{"location":"02-%E8%82%BA/02-09-Bronchiectasis/","text":"","title":"02 09 Bronchiectasis"},{"location":"02-%E8%82%BA/02-10-Cystic-Fibrosis/","text":"","title":"02 10 Cystic Fibrosis"},{"location":"02-%E8%82%BA/02-11-Interstitial-Lung-Disease/","text":"","title":"02 11 Interstitial Lung Disease"},{"location":"02-%E8%82%BA/02-12-Pleural-Effusion/","text":"","title":"02 12 Pleural Effusion"},{"location":"02-%E8%82%BA/02-13-Venous-Thromboembolism/","text":"","title":"02 13 Venous Thromboembolism"},{"location":"02-%E8%82%BA/02-14-Pulmonary-Hypertension/","text":"","title":"02 14 Pulmonary Hypertension"},{"location":"02-%E8%82%BA/02-15-Respiratory-Failure/","text":"see the link","title":"02 15 Respiratory Failure"},{"location":"02-%E8%82%BA/02-16-Mechanical-Ventilation/","text":"","title":"02 16 Mechanical Ventilation"},{"location":"02-%E8%82%BA/02-17-Acute-Respiratory-Distress-Syndrome/","text":"","title":"02 17 Acute Respiratory Distress Syndrome"},{"location":"02-%E8%82%BA/02-18-Sepsis-and-Shock/","text":"","title":"02 18 Sepsis and Shock"},{"location":"02-%E8%82%BA/02-19-Toxicology/","text":"","title":"02 19 Toxicology"},{"location":"02-%E8%82%BA/02-20-Lung-Transplant/","text":"","title":"02 20 Lung Transplant"},{"location":"03-%E8%82%9D%E8%85%B8/03-01-Esophageal-and-Gastric-Disorders/","text":"","title":"03 01 Esophageal and Gastric Disorders"},{"location":"03-%E8%82%9D%E8%85%B8/03-02-Gastrointestinal-Bleeding/","text":"","title":"03 02 Gastrointestinal Bleeding"},{"location":"03-%E8%82%9D%E8%85%B8/03-03-Diarrhea/","text":"","title":"03 03 Diarrhea"},{"location":"03-%E8%82%9D%E8%85%B8/03-04-Dysmotility/","text":"","title":"03 04 Dysmotility"},{"location":"03-%E8%82%9D%E8%85%B8/03-05-Disorders-of-the-Colon/","text":"","title":"03 05 Disorders of the Colon"},{"location":"03-%E8%82%9D%E8%85%B8/03-06-Inflammatory-Bowel-Disease/","text":"","title":"03 06 Inflammatory Bowel Disease"},{"location":"03-%E8%82%9D%E8%85%B8/03-07-Intestinal-Ischemia/","text":"","title":"03 07 Intestinal Ischemia"},{"location":"03-%E8%82%9D%E8%85%B8/03-08-Pancreatitis/","text":"","title":"03 08 Pancreatitis"},{"location":"03-%E8%82%9D%E8%85%B8/03-09-Abnormal-Liver-Tests/","text":"","title":"03 09 Abnormal Liver Tests"},{"location":"03-%E8%82%9D%E8%85%B8/03-10-Hepatitis/","text":"","title":"03 10 Hepatitis"},{"location":"03-%E8%82%9D%E8%85%B8/03-11-Acute-Liver-Failure/","text":"","title":"03 11 Acute Liver Failure"},{"location":"03-%E8%82%9D%E8%85%B8/03-12-Cirrhosis/","text":"","title":"03 12 Cirrhosis"},{"location":"03-%E8%82%9D%E8%85%B8/03-13-Hepatic-Vascular-Disease/","text":"","title":"03 13 Hepatic Vascular Disease"},{"location":"03-%E8%82%9D%E8%85%B8/03-14-Ascites/","text":"","title":"03 14 Ascites"},{"location":"03-%E8%82%9D%E8%85%B8/03-15-Biliary-Tract-Disease/","text":"","title":"03 15 Biliary Tract Disease"},{"location":"04-%E8%85%8E/04-01-Acid-Base-Disturbances/","text":"","title":"04 01 Acid Base Disturbances"},{"location":"04-%E8%85%8E/04-02-Sodium-and-Water-Homeostasis/","text":"","title":"04 02 Sodium and Water Homeostasis"},{"location":"04-%E8%85%8E/04-03-Potassium-Homeostasis/","text":"","title":"04 03 Potassium Homeostasis"},{"location":"04-%E8%85%8E/04-04-Renal-Failure/","text":"","title":"04 04 Renal Failure"},{"location":"04-%E8%85%8E/04-05-Glomerular-Disease/","text":"","title":"04 05 Glomerular Disease"},{"location":"04-%E8%85%8E/04-06-Urinalysis/","text":"","title":"04 06 Urinalysis"},{"location":"04-%E8%85%8E/04-07-Nephrolithiasis/","text":"","title":"04 07 Nephrolithiasis"},{"location":"04-%E8%85%8E/04-08-Acid-Base-Disturbances/","text":"","title":"04 08 Acid Base Disturbances"},{"location":"04-%E8%85%8E/04-09-Sodium-and-Water-Homeostasis/","text":"","title":"04 09 Sodium and Water Homeostasis"},{"location":"04-%E8%85%8E/04-10-Potassium-Homeostasis/","text":"","title":"04 10 Potassium Homeostasis"},{"location":"04-%E8%85%8E/04-11-Renal-Failure/","text":"","title":"04 11 Renal Failure"},{"location":"04-%E8%85%8E/04-12-Glomerular-Disease/","text":"","title":"04 12 Glomerular Disease"},{"location":"04-%E8%85%8E/04-13-Urinalysis/","text":"","title":"04 13 Urinalysis"},{"location":"04-%E8%85%8E/04-14-Nephrolithiasis/","text":"","title":"04 14 Nephrolithiasis"},{"location":"05-%E8%A1%80%E8%85%AB/05-01-Anemia/","text":"","title":"05 01 Anemia"},{"location":"05-%E8%A1%80%E8%85%AB/05-02-Disorders-of-Hemostasis/","text":"","title":"05 02 Disorders of Hemostasis"},{"location":"05-%E8%A1%80%E8%85%AB/05-03-Platelet-Disorders/","text":"","title":"05 03 Platelet Disorders"},{"location":"05-%E8%A1%80%E8%85%AB/05-04-Coagulopathies/","text":"","title":"05 04 Coagulopathies"},{"location":"05-%E8%A1%80%E8%85%AB/05-05-Hypercoagulable-States/","text":"","title":"05 05 Hypercoagulable States"},{"location":"05-%E8%A1%80%E8%85%AB/05-06-Disorders-of-Leukocytes/","text":"","title":"05 06 Disorders of Leukocytes"},{"location":"05-%E8%A1%80%E8%85%AB/05-07-Transfusion-Therapy/","text":"","title":"05 07 Transfusion Therapy"},{"location":"05-%E8%A1%80%E8%85%AB/05-08-Myelodysplastic-Syndromes/","text":"","title":"05 08 Myelodysplastic Syndromes"},{"location":"05-%E8%A1%80%E8%85%AB/05-09-Myeloproliferative-Neoplasms/","text":"","title":"05 09 Myeloproliferative Neoplasms"},{"location":"05-%E8%A1%80%E8%85%AB/05-10-Leukemia-Lymphoma/","text":"","title":"05 10 Leukemia Lymphoma"},{"location":"05-%E8%A1%80%E8%85%AB/05-11-Plasma-Cell-Dyscrasias/","text":"","title":"05 11 Plasma Cell Dyscrasias"},{"location":"05-%E8%A1%80%E8%85%AB/05-12-Hematopoietic-Stem-Cell-Transplantation/","text":"","title":"05 12 Hematopoietic Stem Cell Transplantation"},{"location":"05-%E8%A1%80%E8%85%AB/05-13-Lung-Cancer/","text":"","title":"05 13 Lung Cancer"},{"location":"05-%E8%A1%80%E8%85%AB/05-14-Breast-Cancer/","text":"","title":"05 14 Breast Cancer"},{"location":"05-%E8%A1%80%E8%85%AB/05-15-Prostate-Cancer/","text":"","title":"05 15 Prostate Cancer"},{"location":"05-%E8%A1%80%E8%85%AB/05-16-Colorectal-Cancer/","text":"","title":"05 16 Colorectal Cancer"},{"location":"05-%E8%A1%80%E8%85%AB/05-17-Pancreatic-Tumors/","text":"","title":"05 17 Pancreatic Tumors"},{"location":"05-%E8%A1%80%E8%85%AB/05-18-Hepatocellular-Carcinoma/","text":"","title":"05 18 Hepatocellular Carcinoma"},{"location":"05-%E8%A1%80%E8%85%AB/05-19-Oncologic-Emergencies/","text":"","title":"05 19 Oncologic Emergencies"},{"location":"05-%E8%A1%80%E8%85%AB/05-20-Chemotherapy-Side-Effects/","text":"","title":"05 20 Chemotherapy Side Effects"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/","text":"Pneumonia 2018\u53f0\u7063\u80ba\u708e\u6307\u5f15 Microbiology of Pneumonia Clinical Setting \u539f\u56e0 Community- acquired (CAP) ( NEJM 2014;371:1619 & 373:415; Lancet 2015;386:1097) No pathogen identified in 50\u201360%, virus alone in ~25%, bacteria alone in ~10%, virus-bacteria coinfection in <5% Viruses: influenza, RSV, hMPV, rhinovirus (unknown significance), parainfluenza virus, coronavirus S. pneumoniae (most common bacterial cause) S. aureus (esp. postinfluenza) Mycoplasma, Chlamydia (\u7279\u5225\u5728 young & healthy) H. influenzae, M. catarrhalis (\u7279\u5225\u5728 COPD) Legionella (\u7279\u5225\u5728 elderly, smokers, \u2193 immunity, TNF inhibitors) Klebsiella & other GNR (\u7279\u5225\u5728 alcoholics & aspiration) Hospital-acquired or ventilator-assoc. (HAP/VAP) S. aureus, Pseudo., Klebsiella, E. coli, Enterobacter, Acinetobacter, Stenotrophomonas. IV abx w/in 90 d RF for MDR. Viral~ 20% cases (Chest 2017; 154:1) Immunosuppressed Above + PCP, fungi, Nocardia, non-TB mycobacteria (NTM), CMV Aspiration (NEJM 2019;380:651) Chemical pneumonitis due to aspiration of gastric contents Bacterial pneumonia \u226524\u201372 h after aspiration event outPt: oral flora (strep, S. aureus, anaerobes) inPt or chronically ill: GNR (Pseudomonas) and S. aureus Clinical manifestations Presenting features are variable and depend upon several host factors (esp. age) Classically: fever, cough w/ purulent sputum, consolidation on CXR Atypical pathogens (Legionella, Mycoplasma, Chlamydia, virus): historically classified as \u201catypical\u201d b/c they failed to grow on routine cx. Presentation varies from insidious to acute; imaging features vary from interstitial infiltrates to tree-in-bud opacities, to dense consolid. Clinical and imaging features do NOT distinguish \u201ctypical\u201d from \u201catypical\u201d Aspiration pneumonitis/PNA: can be infectious or non-infectious; may p/w acute inflammatory syndrome (fever, \u2191 WBC, etc.) or insidious course HAP/VAP: develops w/in 48 h after admission or mechanical ventilation, respectively Diagnostic studies Sputum Gram stain/Cx: reliable if high quality (ie, sputum not spit; <10 squamous cells/lpf) & if PNA should be purulent (>25 PMNs/lpf). Yield \u2193 >10 h after abx (CID 2014;58:1782). Blood cultures (before antibiotics!): \u2295 in ~10% of inPts, depending on pathogen Procalcitonin: \u2191 in acute bacterial (not viral) PNA. Consider stopping abx if levels <0.25 ng/ml (<0.5 ng/ml in ICU Pts) or \u2193 \u226580% from peak. \u2193 abx exposure by 2\u20133 d (Lancet ID 2016;16:819 & 2018;18:95). Not validated in immunocompromised hosts. Levels harder to interpret in CKD. False \u2295 in cardiac arrest, shock, surgery. CXR (PA & lateral; see Radiology inserts) \u2192 tap effusions if >5 cm or severe PNA Other: S a O 2 or P a O 2 , arterial pH (if severe), CBC w/ diff, Chem-20; HIV test (if unknown) Other micro based on clinical suspicion (paired serologies available for most atypicals): Mycoplasma: PCR of throat or sputum/BAL before first dose abx Legionella urinary Ag (detects L. pneumophila L1 serotype, 60\u201370% of clinical disease) S. pneumoniae urinary Ag (Se 70%, Sp >90%) MTb: (induced) sputum AFB stain \u00d73 q \u22658h (w/ \u22651 early morning specimen). Myco-bacterial cx (empiric respiratory isolation while pending); MTb DNA PCR if smear \u2295 Viral testing (DFA or PCR) on nasopharyngeal swab or sputum Bronchoscopy: consider if immunosupp., critically ill, failing to respond, VAP, suspected TB or PCP, or inadequate or \u0398 sputum cx. Some pathogens need specific cx media (eg, Legionella on BCYE). Reasons for failure to improve on initial Rx: Insufficient time: may take \u226572 h to see improvement (fever persists >4 d in ~20%) Insufficient drug levels for lung penetration (eg, vanco trough <15\u201320 \u00b5g/mL) Resistant organisms (or superinfxn): eg, MRSA, Pseudo.; consider bronchoscopy Wrong dx: fungal/viral, chemical pneumonitis, PE, CHF, ARDS, DAH, ILD; consider CT Parapneumonic effusion/empyema/abscess: if CXR \u0398, consider CT (dx tap \u00b1 chest tube if effusion present, esp. if loculated) Metastatic infection (eg, endocarditis, meningitis, septic arthritis) Triage qSOFA predicts poor outcomes, prolonged ICU stay, and inhospital mortality if >2 of 3: RR>22, AMS, SBP<100 (JAMA 2016; 315:801) CURB-65: confusion, BUN >20, RR >30, BP <90/60, age >65 If score 0\u20131: Rx as outpt; 2: Rx as inpt; >3 consider ICU (Thorax 2013; 58:377) Treatment Scenario Regimen Special Considerations CAP (outPt) Azithro or doxy Avoid azithro/doxycycline if >25% resist- ance locally. Use FQ OR B-lactam + azithro/doxy. CAP (ward) Resp FQ or [3 rd -gen ceph + azithro] Doxycycline can replace azithro Omadacycline \u2248 FQ (NEJM 2019;380:517) CAP (ICU) Resp FQ + [3 rd -gen ceph or amp-sulbactam] Only cover MRSA or Pseudomonas if risk factors. If resp FQ contraindic., use azithro HCAP (incl. VAP) [Pip-tazo or cefepime or carbapen.] + [vanco or linezolid]395 May add resp FQ (or azithro) when concerned re: atypicals Aspiration Treat if abnl CXR (or if need to be intubated or develops septic shock) Amox-clav, amp-sulbactam, FQ, carbapenem If hosp-acquired and concern for multidrug-resistant pathogens: [pip-tazo, cefepime, or carbapenem] + [AG or colistin] Avoid quinolones if suspect TB Steroids: not standard practice, but appear to \u2193 mortality, mech vent, & ARDS (Cochrane 2017;12:CD007720). Consider in severe CAP (F i O 2 >0.5 + \u22651 of: pH<7.3; lactate >4; CRP >150). Avoid in suspected or known influenza. Dosing: pred 50 mg PO \u00d77 d or methylpred 0.5 mg/kg IV BID \u00d75 d. Duration: for CAP, 5 d if stable & afebrile for 48\u201372 h; for HAP/VAP, 8 d (CID 2017; 65:8) When possible, de-escalate abx based on sensitivities Prognosis For low-risk Pts, can discharge immediately after switching to PO abx (CID 2007;44:S27) CXR resolves in most by 6 wk; consider f/u to r/o underlying malig (esp. if >50 y or smoker) Prevention All persons >65: give PCV13 vaccine followed by PPSV23 vaccine 1 y later. If PPSV23 already received, give PCV13. Age 19\u201364 w/ CHF/CMP, lung disease (including asthma), cirrhosis, DM, EtOH, or smoker: give PPSV23 Any age w/ immunocomp., CSF leak, cochlear implant, asplenia: give PCV13 followed by PPSV23 8 wks later. Smoking cessation counseling VAP precautions: HOB >30\u00b0, chlorhexidine rinse; aspiration precautions in high-risk Pts","title":"Pneumonia"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#pneumonia","text":"2018\u53f0\u7063\u80ba\u708e\u6307\u5f15","title":"Pneumonia"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#microbiology-of-pneumonia","text":"Clinical Setting \u539f\u56e0 Community- acquired (CAP) ( NEJM 2014;371:1619 & 373:415; Lancet 2015;386:1097) No pathogen identified in 50\u201360%, virus alone in ~25%, bacteria alone in ~10%, virus-bacteria coinfection in <5% Viruses: influenza, RSV, hMPV, rhinovirus (unknown significance), parainfluenza virus, coronavirus S. pneumoniae (most common bacterial cause) S. aureus (esp. postinfluenza) Mycoplasma, Chlamydia (\u7279\u5225\u5728 young & healthy) H. influenzae, M. catarrhalis (\u7279\u5225\u5728 COPD) Legionella (\u7279\u5225\u5728 elderly, smokers, \u2193 immunity, TNF inhibitors) Klebsiella & other GNR (\u7279\u5225\u5728 alcoholics & aspiration) Hospital-acquired or ventilator-assoc. (HAP/VAP) S. aureus, Pseudo., Klebsiella, E. coli, Enterobacter, Acinetobacter, Stenotrophomonas. IV abx w/in 90 d RF for MDR. Viral~ 20% cases (Chest 2017; 154:1) Immunosuppressed Above + PCP, fungi, Nocardia, non-TB mycobacteria (NTM), CMV Aspiration (NEJM 2019;380:651) Chemical pneumonitis due to aspiration of gastric contents Bacterial pneumonia \u226524\u201372 h after aspiration event outPt: oral flora (strep, S. aureus, anaerobes) inPt or chronically ill: GNR (Pseudomonas) and S. aureus","title":"Microbiology of Pneumonia"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#clinical-manifestations","text":"Presenting features are variable and depend upon several host factors (esp. age) Classically: fever, cough w/ purulent sputum, consolidation on CXR Atypical pathogens (Legionella, Mycoplasma, Chlamydia, virus): historically classified as \u201catypical\u201d b/c they failed to grow on routine cx. Presentation varies from insidious to acute; imaging features vary from interstitial infiltrates to tree-in-bud opacities, to dense consolid. Clinical and imaging features do NOT distinguish \u201ctypical\u201d from \u201catypical\u201d Aspiration pneumonitis/PNA: can be infectious or non-infectious; may p/w acute inflammatory syndrome (fever, \u2191 WBC, etc.) or insidious course HAP/VAP: develops w/in 48 h after admission or mechanical ventilation, respectively","title":"Clinical manifestations"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#diagnostic-studies","text":"Sputum Gram stain/Cx: reliable if high quality (ie, sputum not spit; <10 squamous cells/lpf) & if PNA should be purulent (>25 PMNs/lpf). Yield \u2193 >10 h after abx (CID 2014;58:1782). Blood cultures (before antibiotics!): \u2295 in ~10% of inPts, depending on pathogen Procalcitonin: \u2191 in acute bacterial (not viral) PNA. Consider stopping abx if levels <0.25 ng/ml (<0.5 ng/ml in ICU Pts) or \u2193 \u226580% from peak. \u2193 abx exposure by 2\u20133 d (Lancet ID 2016;16:819 & 2018;18:95). Not validated in immunocompromised hosts. Levels harder to interpret in CKD. False \u2295 in cardiac arrest, shock, surgery. CXR (PA & lateral; see Radiology inserts) \u2192 tap effusions if >5 cm or severe PNA Other: S a O 2 or P a O 2 , arterial pH (if severe), CBC w/ diff, Chem-20; HIV test (if unknown) Other micro based on clinical suspicion (paired serologies available for most atypicals): Mycoplasma: PCR of throat or sputum/BAL before first dose abx Legionella urinary Ag (detects L. pneumophila L1 serotype, 60\u201370% of clinical disease) S. pneumoniae urinary Ag (Se 70%, Sp >90%) MTb: (induced) sputum AFB stain \u00d73 q \u22658h (w/ \u22651 early morning specimen). Myco-bacterial cx (empiric respiratory isolation while pending); MTb DNA PCR if smear \u2295 Viral testing (DFA or PCR) on nasopharyngeal swab or sputum Bronchoscopy: consider if immunosupp., critically ill, failing to respond, VAP, suspected TB or PCP, or inadequate or \u0398 sputum cx. Some pathogens need specific cx media (eg, Legionella on BCYE). Reasons for failure to improve on initial Rx: Insufficient time: may take \u226572 h to see improvement (fever persists >4 d in ~20%) Insufficient drug levels for lung penetration (eg, vanco trough <15\u201320 \u00b5g/mL) Resistant organisms (or superinfxn): eg, MRSA, Pseudo.; consider bronchoscopy Wrong dx: fungal/viral, chemical pneumonitis, PE, CHF, ARDS, DAH, ILD; consider CT Parapneumonic effusion/empyema/abscess: if CXR \u0398, consider CT (dx tap \u00b1 chest tube if effusion present, esp. if loculated) Metastatic infection (eg, endocarditis, meningitis, septic arthritis)","title":"Diagnostic studies"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#triage","text":"qSOFA predicts poor outcomes, prolonged ICU stay, and inhospital mortality if >2 of 3: RR>22, AMS, SBP<100 (JAMA 2016; 315:801) CURB-65: confusion, BUN >20, RR >30, BP <90/60, age >65 If score 0\u20131: Rx as outpt; 2: Rx as inpt; >3 consider ICU (Thorax 2013; 58:377)","title":"Triage"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#treatment","text":"Scenario Regimen Special Considerations CAP (outPt) Azithro or doxy Avoid azithro/doxycycline if >25% resist- ance locally. Use FQ OR B-lactam + azithro/doxy. CAP (ward) Resp FQ or [3 rd -gen ceph + azithro] Doxycycline can replace azithro Omadacycline \u2248 FQ (NEJM 2019;380:517) CAP (ICU) Resp FQ + [3 rd -gen ceph or amp-sulbactam] Only cover MRSA or Pseudomonas if risk factors. If resp FQ contraindic., use azithro HCAP (incl. VAP) [Pip-tazo or cefepime or carbapen.] + [vanco or linezolid]395 May add resp FQ (or azithro) when concerned re: atypicals Aspiration Treat if abnl CXR (or if need to be intubated or develops septic shock) Amox-clav, amp-sulbactam, FQ, carbapenem If hosp-acquired and concern for multidrug-resistant pathogens: [pip-tazo, cefepime, or carbapenem] + [AG or colistin] Avoid quinolones if suspect TB Steroids: not standard practice, but appear to \u2193 mortality, mech vent, & ARDS (Cochrane 2017;12:CD007720). Consider in severe CAP (F i O 2 >0.5 + \u22651 of: pH<7.3; lactate >4; CRP >150). Avoid in suspected or known influenza. Dosing: pred 50 mg PO \u00d77 d or methylpred 0.5 mg/kg IV BID \u00d75 d. Duration: for CAP, 5 d if stable & afebrile for 48\u201372 h; for HAP/VAP, 8 d (CID 2017; 65:8) When possible, de-escalate abx based on sensitivities","title":"Treatment"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#prognosis","text":"For low-risk Pts, can discharge immediately after switching to PO abx (CID 2007;44:S27) CXR resolves in most by 6 wk; consider f/u to r/o underlying malig (esp. if >50 y or smoker)","title":"Prognosis"},{"location":"06-%E6%84%9F%E6%9F%93/06-01-Pneumonia/#prevention","text":"All persons >65: give PCV13 vaccine followed by PPSV23 vaccine 1 y later. If PPSV23 already received, give PCV13. Age 19\u201364 w/ CHF/CMP, lung disease (including asthma), cirrhosis, DM, EtOH, or smoker: give PPSV23 Any age w/ immunocomp., CSF leak, cochlear implant, asplenia: give PCV13 followed by PPSV23 8 wks later. Smoking cessation counseling VAP precautions: HOB >30\u00b0, chlorhexidine rinse; aspiration precautions in high-risk Pts","title":"Prevention"},{"location":"06-%E6%84%9F%E6%9F%93/06-02-Fungal-Infections/","text":"","title":"06 02 Fungal Infections"},{"location":"06-%E6%84%9F%E6%9F%93/06-03-Infections-in-Immunosuppressed-Hosts/","text":"","title":"06 03 Infections in Immunosuppressed Hosts"},{"location":"06-%E6%84%9F%E6%9F%93/06-04-Urinary-Tract-Infections/","text":"add some new words","title":"06 04 Urinary Tract Infections"},{"location":"06-%E6%84%9F%E6%9F%93/06-05-Soft-Tissue-and-Bone-Infections/","text":"","title":"06 05 Soft Tissue and Bone Infections"},{"location":"06-%E6%84%9F%E6%9F%93/06-06-Infections-of-the-Nervous-System/","text":"","title":"06 06 Infections of the Nervous System"},{"location":"06-%E6%84%9F%E6%9F%93/06-07-Bacteremia-and-Endocarditis/","text":"","title":"06 07 Bacteremia and Endocarditis"},{"location":"06-%E6%84%9F%E6%9F%93/06-08-Tuberculosis/","text":"","title":"06 08 Tuberculosis"},{"location":"06-%E6%84%9F%E6%9F%93/06-09-HIV-AIDS/","text":"","title":"06 09 HIV AIDS"},{"location":"06-%E6%84%9F%E6%9F%93/06-10-Tick-Borne-Diseases/","text":"","title":"06 10 Tick Borne Diseases"},{"location":"06-%E6%84%9F%E6%9F%93/06-11-Fever-Syndromes/","text":"","title":"06 11 Fever Syndromes"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-01-Pituitary-Disorders/","text":"","title":"07 01 Pituitary Disorders"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-02.Thyroid-Disorders/","text":"","title":"07 02.Thyroid Disorders"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-03-Adrenal-Disorders/","text":"","title":"07 03 Adrenal Disorders"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-04-Calcium-Disorders/","text":"","title":"07 04 Calcium Disorders"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-05-Diabetes-Mellitus/","text":"","title":"07 05 Diabetes Mellitus"},{"location":"07-%E5%85%A7%E5%88%86%E6%B3%8C/07-06-Lipid-Disorders/","text":"","title":"07 06 Lipid Disorders"},{"location":"08-%E9%A2%A8%E5%85%8D/08-01-Approach-to-Rheumatic-Disease/","text":"","title":"08 01 Approach to Rheumatic Disease"},{"location":"08-%E9%A2%A8%E5%85%8D/08-02-Rheumatoid-Arthritis/","text":"","title":"08 02 Rheumatoid Arthritis"},{"location":"08-%E9%A2%A8%E5%85%8D/08-03-Adult-Onset-Still%E2%80%99s-Disease-and-Relapsing-Polychondritis/","text":"","title":"08 03 Adult Onset Still\u2019s Disease and Relapsing Polychondritis"},{"location":"08-%E9%A2%A8%E5%85%8D/08-04-Crystal-Deposition-Arthritides/","text":"","title":"08 04 Crystal Deposition Arthritides"},{"location":"08-%E9%A2%A8%E5%85%8D/08-05-Seronegative-Spondyloarthritis/","text":"","title":"08 05 Seronegative Spondyloarthritis"},{"location":"08-%E9%A2%A8%E5%85%8D/08-06-Infectious-Arthritis-and-Bursitis/","text":"","title":"08 06 Infectious Arthritis and Bursitis"},{"location":"08-%E9%A2%A8%E5%85%8D/08-07-Connective-Tissue-Diseases/","text":"","title":"08 07 Connective Tissue Diseases"},{"location":"08-%E9%A2%A8%E5%85%8D/08-08-Systemic-Lupus-Erythematosus/","text":"","title":"08 08 Systemic Lupus Erythematosus"},{"location":"08-%E9%A2%A8%E5%85%8D/08-09-Vasculitis/","text":"","title":"08 09 Vasculitis"},{"location":"08-%E9%A2%A8%E5%85%8D/08-10-IgG4-Related-Disease/","text":"","title":"08 10 IgG4 Related Disease"},{"location":"08-%E9%A2%A8%E5%85%8D/08-11-Cryoglobulinemia/","text":"","title":"08 11 Cryoglobulinemia"},{"location":"08-%E9%A2%A8%E5%85%8D/08-12-Amyloidosis/","text":"","title":"08 12 Amyloidosis"},{"location":"09-%E7%A5%9E%E5%85%A7/09-01-Change-in-Mental-Status/","text":"","title":"09 01 Change in Mental Status"},{"location":"09-%E7%A5%9E%E5%85%A7/09-02-Seizures/","text":"","title":"09 02 Seizures"},{"location":"09-%E7%A5%9E%E5%85%A7/09-03-Alcohol-Withdrawal/","text":"","title":"09 03 Alcohol Withdrawal"},{"location":"09-%E7%A5%9E%E5%85%A7/09-04-Dizziness/","text":"","title":"09 04 Dizziness"},{"location":"09-%E7%A5%9E%E5%85%A7/09-05-Stroke/","text":"","title":"09 05 Stroke"},{"location":"09-%E7%A5%9E%E5%85%A7/09-06-Weakness-and-Neuromuscular-Dysfunction/","text":"","title":"09 06 Weakness and Neuromuscular Dysfunction"},{"location":"09-%E7%A5%9E%E5%85%A7/09-07-Headache/","text":"","title":"09 07 Headache"},{"location":"09-%E7%A5%9E%E5%85%A7/09-08-Back-and-Spinal-Cord-Disease/","text":"","title":"09 08 Back and Spinal Cord Disease"}]}